Mobile app for acne geared to teenagers

Cutanea Life Sciences announced the introduction a new mobile application for patients who are prescribed Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination erythromycin and benzoyl peroxide therapy indicated for the topical treatment of acne vulgaris.

"Most teens today have three things in common: they have acne, they're always on the go, and they're into digital technology, including smartphones and the 'selfie' phenomenon," Daniel Roling, MD, a Philadelphia area dermatologist, stated in a news release. "For teenagers prescribed Aktipak, the 'Facing Forward' mobile app should be a welcome and valuable aid in monitoring compliance and treatment progress."

Features of the app include a camera function that enables users to take a "photo journal" of their face and track their progress while they are undergoing treatment with Aktipak, according to the release. Other features include an instructional video on how to mix the product, dosing reminders, prescription refill reminders, a compliance report and acne information resources.

The app will be available free through the Apple Store or Google Play, according to Cutanea Life Sciences.

Aktipak is a portable, freshly mixed, patient-blended therapy. The product comes in pocket-sized, single-dose, dual-chamber pouches, each of which contain antibiotic erythromycin and antibacterial benzoyl peroxide in separate chambers. The patient is instructed to open the pouch and blend the gel contents immediately prior to use.

The product is contraindicated in individuals who have shown hypersensitivity to any of its components, according to the release.

Reference: www.cutanea.com